Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials

@article{Witt2019KetamineFS,
  title={Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials},
  author={Katrina Witt and Jennifer Potts and Anna A M Hubers and Michael F Grunebaum and James W. Murrough and Colleen K. Loo and Andrea Cipriani and Keith Hawton},
  journal={Australian \& New Zealand Journal of Psychiatry},
  year={2019},
  volume={54},
  pages={29 - 45}
}
Objective: Ketamine may reduce suicidal ideation in treatment-resistant depression. But it is not known how quickly this occurs and how long it persists. We undertook a systematic review and meta-analysis to determine the short- and long-term effectiveness of ketamine for suicidality. Method: CENTRAL, EMBASE, Medline, and PsycINFO were searched until 12 December 2018. Randomised controlled trials of ketamine or esketamine reporting data on suicidal ideation, self-harm, attempted or completed… Expand
Ketamine for Bipolar Depression: A Systematic Review
TLDR
Some preliminary evidence supporting use of intravenous racemic ketamine to treat adults with bipolar depression is found, with Ketamine was reasonably well tolerated; however, 2 participants developed manic symptoms. Expand
Ketamine treatment for individuals with treatment-resistant depression: longitudinal qualitative interview study of patient experiences
TLDR
Ketamine treatment was generally experienced as effective in improving mood and reducing suicidal ideation in the short term, but the lack of longer-term benefit was challenging for participants, as was treatment cost. Expand
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.
TLDR
Intravenous ketamine appears to be more efficacious than intranasal esketamine for the treatment of depression. Expand
Ketamine and esketamine for suicidal ideation: Recent progress and practical issues
TLDR
The metaanalysis of Witt and colleagues (2020) tested the efficacy of ketamine for suicidal ideation in adults with major depressive or bipolar disorders and found a moderate reduction in suicidal Ideation 4 hours after ketamine’s infusion, which persisted until 72 hours. Expand
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial.
TLDR
When administered in the appropriate context, ayahuasca may lead to rapid and sustained reductions in suicidality among individuals with MDD. Expand
Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide Risk
TLDR
The history and the current understanding of the role of ketamine and esketamine in depression and suicidal ideation and behavior are discussed and a consistent picture of benefits that appears to outweigh the potential risks of the treatment is drawn. Expand
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder.
TLDR
Only ketamine appeared to be more efficacious than placebo 24 hours after infusion for response rate and depression rating scale scores, and the acceptability of ketamine and other glutamate receptor modulators in people with bipolar disorder was reviewed. Expand
The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study
TLDR
A single infusion of IV ketamine may reduce suicidal ideation in patients with treatment-resistant depression out to 30 days post infusion, but early anti-suicidal effects appear to diminish rapidly. Expand
Suicide in psychiatric disorders: rates, risk factors, and therapeutics
TLDR
Lithium is underutilized clinically but has substantial evidence of long-term preventive effects on attempts and suicide in bipolar disorder (BD), and possibly also in patients with major depressive disorder (MDD) and some second-generation antipsychotics have evidence of efficacy in depression, particularly acute bipolar depression. Expand
The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis.
TLDR
The findings suggest that single-dose IV ketamine/IN esketamine is associated with robust reductions in suicidal thoughts at 2-h, 4-h and 24-h post-intervention. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 67 REFERENCES
Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
TLDR
The effect of IV ketamine on suicidal ideation was large and significant, with effects comparable between IV bolus and infusion ketamine, and relevant, emerging evidence should be considered as ‘very low’ so far. Expand
Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature
TLDR
Consistent with clinical research on ketamine as a rapid and effective treatment for depression, ketamine has shown early preliminary evidence of a reduction in depressive symptoms, as well as reducing SI, with minimal short-term side effects. Expand
Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.
TLDR
Data from two randomized, placebo-controlled, crossover clinical trials evaluating ketamine in individuals with treatment-resistant depression suggest that repeated suicidal assessments over minutes to days appear to detect improvement in suicidal thoughts after ketamine infusion compared to placebo. Expand
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
TLDR
Ketamine rapidly reduced suicidal thoughts, within 1 day and for up to 1 week in depressed patients with suicidal ideation, although subsequent trials in transdiagnostic samples are required to confirm that ketamine exerts a specific effect on suicidal Ideation. Expand
Ketamine administration in depressive disorders: a systematic review and meta-analysis
TLDR
The present meta-analysis confirms ketamine’s efficacy in depressive disorders in non-ECT studies, as well as in ECT studies, and further studies are warranted to detail efficacy in bipolar disorders and other specific depressed populations. Expand
Suicidal ideation and subsequent completed suicide in both psychiatric and non-psychiatric populations: a meta-analysis
TLDR
This meta-analysis of cohort and case–control studies that assessed suicidal ideation as determinant for completed suicide in adults found that expression of suicidal Ideation in psychiatric patients should prompt secondary prevention strategies to reduce their substantial increased risk of suicide. Expand
Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
TLDR
Suicidal ideation in the context of MDD improved within 40 minutes of a ketamine infusion and remained improved for up to 4 hours postinfusion. Expand
Treatment-resistant depression and suicidality.
TLDR
The completed and attempted suicide incidences are high, but these incidences did not differ between three end of the line treatments (DBS, VNS or ECT). Expand
Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
TLDR
Low-dose ketamine appears more effective than very low dose, but there is substantial heterogeneity in clinical response, with remission among one-fifth of patients at 1 week but most others having benefits that are less durable. Expand
Psychosocial interventions following self-harm in adults: a systematic review and meta-analysis.
TLDR
A Cochrane systematic review and meta-analysis of the effectiveness of psychosocial interventions for self-harm in adults found CBT seems to be effective in patients after self- Harm, and there were few trials of other promising interventions, precluding firm conclusions as to their effectiveness. Expand
...
1
2
3
4
5
...